Atai Beckley N V Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons :

Growth Rates ▼

Select the Ratio:

None▼

Growth Rates ▼

None▼

Download as CSV

ATAI Revenue Growth Rate Comparisons	Company	Industry	Sector	S&P 500
Y / Y Revenue Growth (Q3 MRQ)	1772.5 %	10.1 %	7.64 %	7.96 %
Q / Q Revenue Growth (Q3 MRQ)	4.17 %	6.05 %	4.36 %	4.62 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM)	811.78 %	9.32 %	7.79 %	%
Sequential Revenue Growth (for 12 months ending Q3 TTM)	30.71 %	2.33 %	2.18 %	1.99 %
Revenue 5 Year Average Growth	-	9.02 %	8.22 %	7.56 %

ATAI's Growth Comparisons in III. Quarter 2025

Atai Beckley N V reported top-line of $ 1 millions in the third quarter 2025, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry grew by 10.1%, while the top-line in the Healthcare sector increased by 7.64%, and overall market improved by 7.96% from the third quarter 2024.

Comparing the company's Revenue to the second quarter results, sales were higher by 4.17% . On the yearly basis, average annual sales growth for Atai Beckley N V is %, while S & P 500's including only Businesses with the third quarter 2025 earnings, average annual sales growth is 7.56% over the past five years.

ATAI Growth Rates by Company's Segments

Segment Name	Y / Y	Sequential
Research and development services revenue	-	4.17 %
Research and development services revenue Reportable Aggregation before Other Segment	-	4.17 %
Total	1772.5 %	4.17 %

Growth Rates of ATAI's Income in the third quarter 2025

ATAI Operating Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Operating Income Change (Q3 MRQ)	-	34.93 %	28.02 %	15.18 %
Sequential Operating Income Change (Q3 MRQ)	-	12.52 %	10.35 %	7.5 %
Y / Y Operating Income Growth (Q3 TTM)	-	93.58 %	56.5 %	6.78 %
Sequential Operating Income Growth (Q3 TTM)	-	9.05 %	6.52 %	3.69 %
Operating Income 5 Year Avg. Change	-	-1.79 %	-1.82 %	9.14 %

Income from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ)	-	54.05 %	30.77 %	19.52 %
Sequential Income from Cont. Ops. Change (Q3 MRQ)	-	14.96 %	14.73 %	2.98 %
Y / Y Income from Cont. Ops. Change (Q3 TTM)	-	143.99 %	101.35 %	14.87 %
Sequential Income from Cont. Ops. Change (Q3 TTM)	-	12.81 %	7.66 %	4.59 %
Income from Cont. Ops. 5 Year Avg. Change	-	-3.66 %	-9.06 %	9.13 %

ATAI Net Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Net Income Growth (Q3 MRQ)	-	55.7 %	20.24 %	18.78 %
Q / Q Net Income Growth (Q3 MRQ)	-	15.14 %	15.68 %	3.06 %
Y / Y Net Income Change (Q3 TTM)	-	144.98 %	88.7 %	15.72 %
Sequential Net Income Change (Q3 TTM)	-	12.79 %	4.81 %	4.42 %
Net Income 5 Year Avg. Growth	-	-4.66 %	-8.54 %	8.69 %

ATAI's EPS Growth Rates

EPS from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ)	-	51.25 %	30.77 %	19.52 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ)	-	13.01 %	14.73 %	2.98 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM)	-	-	-	-
Sequential EPS from Cont. Ops. Change (Q3 TTM)	-	-	-	-47.95 %
EPS from Cont. Ops. 5 Year Avg. Growth	-	-11.79 %	-9.06 %	9.13 %

ATAI EPS Net Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS Net Growth (Q3 MRQ)	-	52.87 %	20.24 %	9.13 %
Q / Q EPS Net Growth (Q3 MRQ)	-	13.18 %	15.68 %	3.06 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM)	-	-	-	-66.91 %
Sequential EPS Net Change (for 12 months ending Q3 TTM)	-	-	-	-47.94 %
EPS Net 5 Year Avg. Change	-	-4.66 %	-8.54 %	8.69 %

Atai Beckley N V reported bottom-line of $ -0.28 in the third quarter, compare to $ -0.16 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 52.87%, while Healthcare sector increased by 20.24%, and overall market improved by 18.78%.

Comparing company's EPS to the second quarter results, income per share were higher by 4.17% . On the yearly basis, average annual income per share growth for Atai Beckley N V is %, while S & P 500's including only the businesses with the third quarter 2025 Results, average annual income per share growth is 8.69% over the past five years.

ATAI Cash Flow Growth Rates

Free Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ)	-	13.13 %	21.57 %	76.78 %
Sequential Free Cash Flow Change (Q3 MRQ)	-	120.43 %	100.38 %	27.6 %
Y / Y Free Cash Flow Change (Q3 TTM)	-	20.81 %	17.93 %	19.84 %
Sequential Free Cash Flow Change (Q3 TTM)	-	5.57 %	6.97 %	13.42 %
Free Cash Flow 5 Year Avg. Change	-	9 %	4.78 %	8.26 %

Net Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ)	-	-	-	-
Sequential Net Cash Flow Change (Q3 MRQ)	-	-	-	-
Y / Y Net Cash Flow Change (Q3 TTM)	-	-	527.52 %	-
Sequential Net Cash Flow Change (Q3 TTM)	-	-	-	-
Net Cash Flow 5 Year Avg. Change	-	-31.22 %	-19.37 %	0.42 %

Capital Expenditures	Company	Industry	Sector	S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ)	536200 %	19.01 %	10.82 %	22.55 %
Sequential Capital Expenditures Change (Q3 MRQ)	4122.83 %	15.26 %	12.67 %	8.68 %
Y / Y Capital Expenditures Change (Q3 TTM)	47060.87 %	17.2 %	7.36 %	23.2 %
Sequential Capital Expenditures Change (Q3 TTM)	97.76 %	6.43 %	3.1 %	5.37 %
Capital Expenditures 5 Year Avg. Change	-	9.47 %	8.03 %	7.58 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

Dividend Comparisons

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.